Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Barbara Budzyńska"'
Autor:
Monika Maciąg, Maria Zykubek, Agnieszka Michalak, Krystyna Skalicka-Woźniak, Barbara Budzyńska, Andrzej Ciszewski
Publikováno v:
Brain Research Bulletin. 165:139-145
The ever-present trend for introducing new drugs of natural origin with anxiolytic properties meets healthcare needs of the population, whose almost 34 % struggles with anxiety-related disorders. At the same time, animal assays that could serve as fa
Autor:
Gill M. Enslin, Krystyna Skalicka-Woźniak, Veronica B Maphanga, Alvaro M. Viljoen, Barbara Budzyńska
Publikováno v:
Psychopharmacology. 237:3641-3652
Medicinal plants are used extensively in many countries to treat conditions related to the central nervous system (CNS), and there is renewed interest to explore natural products, which may exhibit CNS activity. In this study, seven plants were selec
Autor:
Laurence Marcourt, Monika Maciąg, Jean-Luc Wolfender, Jarosław Widelski, Barbara Budzyńska, Krystyna Skalicka-Woźniak, Adrianna Skiba, Simon Vlad Luca
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 1829, p 1829 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 4
International Journal of Molecular Sciences
Volume 22
Issue 4
Different types of anxiety disorders have become the number one mental health issue in developed countries. The search for new, safer and effective drug-like molecules among naturally derived substances faces two difficulties: an efficient method of
Autor:
Artur Wnorowski, Alessia Berardinelli, Agnieszka Michalak, Jakub Rusinek, Barbara Budzyńska, Sara Zinato
Publikováno v:
Neuropharmacology. 180:108302
Intracellular signalling pathways have been extensively studied as therapeutic targets for the treatment of mental diseases. Our attention has been caught by two kinases potentially involved in anxiety, ERK1/2 and CaMKII. The study aimed to examine c
Publikováno v:
Neurotoxicity Research
A growing body of psychiatric research has emerged, focusing on the role of endocannabinoid system in psychiatric disorders. For example, the endocannabinoid system, via cannabinoid CB (CB1 and CB2) receptors, is able to control the function of many
Publikováno v:
Pharmacological Reports. 64:1066-1080
Background and Methods Several lines of evidence support a strong relationship between cholinergic pathways and memory. The aim of our experiments was to examine the mechanisms involved in the formation of different memory stages, to evaluate the imp
Publikováno v:
Behavioural Brain Research. 228:144-150
The motivational component of drug withdrawal may contribute to drug seeking and relapse through the negative reinforcement-related process; thus, it is important to understand the mechanisms that mediate affective withdrawal behaviors. The present s
Publikováno v:
Neural Plasticity
Neural Plasticity, Vol 2016 (2016)
Neural Plasticity, Vol 2016 (2016)
The endocannabinoid system, through cannabinoid (CB) receptors, is involved in memory-related responses, as well as in processes that may affect cognition, like oxidative stress processes. The purpose of the experiments was to investigate the impact
Effects of acute and chronic nicotine on elevated plus maze in mice: Involvement of calcium channels
Autor:
Barbara Budzyńska, Grazyna Biala
Publikováno v:
Life Sciences. 79:81-88
The current experiments examined the anxiety-related effects of acute and repeated nicotine administration using the elevated plus maze test in mice. Nicotine (0.1 mg/kg s.c., 5 and 30 min after injection; 0.5 mg/kg, s.c., 5 min after injection) had
Autor:
Barbara Budzyńska, Marta Kruk-Slomka, Grazyna Biala, Krystyna Skalicka-Wozniak, Kazimierz Głowniak
Publikováno v:
Experimental and clinical psychopharmacology. 20(4)
The purpose of the reported experiments was to examine the effects of imperatorin [9-(3-methylbut-2-enyloxy)-7H-furo[3,2-g]chromen-7-one], a bioactive furanocoumarin isolated from the fruits of Angelica archangelica (Angelica officinalis) on anxiety